November 26, 2013
Travelers Indemnity Co. on Monday asked a federal judge not to toss its $47 million lawsuit claiming it overpaid Pfizer Inc. for the epilepsy drug Neurontin due to the drugmaker's anti-competitive efforts and aggressive marketing of off-label uses, saying its claims are not time-barred.
July 18, 2012
Travelers Indemnity Co. and several of its affiliates on Wednesday filed a $47 million suit against Pfizer Inc. claiming they overpaid for epilepsy drug Neurontin because of its anti-competitive efforts to keep generics out of the market and its aggressive marketing of off-label uses.